The popularity of direct anterior approach THA is driving new product introductions.
With the exploding growth of enabling technology, much of the focus on implant solutions in recent years has been on knee replacement systems compatible with enabling technologies. At the same time, minimally invasive techniques for hip replacement using the direct anterior approach (DAA) have rapidly been gaining favor among surgeons. More companies are designing implant solutions to facilitate DAA, for use with and without enabling technologies. At this year’s American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, manufacturers were showcasing not one, but four new hip systems specifically designed to facilitate the direct anterior approach. Because surgeon adoption of this technique appears to be accelerating, it is potentially a significant opportunity for implant companies. In a 2022 survey of its members, AAHKS found that DAA was the most utilized for primary total hip arthroplasty THA (56%), a significant increase from 2018 when 40% of AAHKS surgeons indicated they used an anterior approach.
The introduction of these new stems almost plays out like a David vs Goliath story with two smaller US market players, NextStep Arthropedix and Corin, facing two of the four largest, Zimmer Biomet and Smith+Nephew. In this downloadable article, SmartTRAK looks at these new stems hitting the US market, including a brief history of the stems, their features and benefits, and the market positioning for each.
- NextStep Arthropedix
NextStep, founded in 2014 by medical device entrepreneur Randy Theken, leveraged the technology from its original hip system, iNSitu, to design its TheRay Hip System. NextStep featured... (read more) - Corin Group
Corin announced the 510(k) clearance and introduction of its new Icona Hip Stem the week of AAHKS 2024. Icona is a ... (read more) - Zimmer Biomet
Before announcing the broad commercial launch of the Z1 Femoral Hip System at AAHKS 2024, Zimmer Biomet via Orchard Medical Development received 510(k) clearance for ... (read more) - Smith+Nephew
Smith+Nephew featured their new CATALYSTEM at AAHKS 2024, just a little over a month after its September announcement of ... (read more)
The unveiling of four new hip systems at AAHKS 2024 underscores the ongoing innovation within the orthopedic implant market, particularly in solutions tailored to the direct anterior approach. With DAA adoption surging among surgeons, as evidenced by the AAHKS survey, these systems are addressing a growing demand for minimally invasive, muscle-sparing techniques that align with the broader shift toward outpatient procedures in ASC settings.
Curious about the latest trends in direct anterior hip solutions? Discover the latest insights on the four new hip systems from industry expert Lisa Mahan, SmartTRAK's VP of Product Development & IT, Sr. Analyst Total Joints. Click below to read her comprehensive market perspective article "AAHKS 2024: Showcasing Direct Anterior Hip Solutions." 
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.
